Your browser doesn't support javascript.
loading
Downregulation of peripheral lipopolysaccharide binding protein impacts on perigonadal adipose tissue only in female mice.
Comas, Ferran; Díaz-Trelles, Ramon; Gavaldà-Navarro, Aleix; Milbank, Edward; Dragano, Nathalia; Morón-Ros, Samantha; Mukthavaram, Rajesh; Latorre, Jessica; Ortega, Francisco; Arnoriaga-Rodriguez, Maria; Oliveras-Cañellas, Núria; Ricart, Wifredo; Karmali, Priya P; Tachikawa, Kiyoshi; Chivukula, Pad; Villarroya, Francesc; Giralt, Marta; López, Miguel; Fernández-Real, José Manuel; Moreno-Navarrete, José María.
Afiliação
  • Comas F; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdIBGi) and Hospital of Girona "Dr Josep Trueta", 17007 Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain.
  • Díaz-Trelles R; Arcturus Therapeutics, San Diego, CA 92121, USA.
  • Gavaldà-Navarro A; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain; Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine (IBUB), University of Barcelona, Av. Diagonal 643, 08028 Barcelona, Catalonia, Spain.
  • Milbank E; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain; NeurObesity Group, Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela 15782, Spain.
  • Dragano N; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain; NeurObesity Group, Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela 15782, Spain.
  • Morón-Ros S; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain; Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine (IBUB), University of Barcelona, Av. Diagonal 643, 08028 Barcelona, Catalonia, Spain.
  • Mukthavaram R; Arcturus Therapeutics, San Diego, CA 92121, USA.
  • Latorre J; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdIBGi) and Hospital of Girona "Dr Josep Trueta", 17007 Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain.
  • Ortega F; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdIBGi) and Hospital of Girona "Dr Josep Trueta", 17007 Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain.
  • Arnoriaga-Rodriguez M; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdIBGi) and Hospital of Girona "Dr Josep Trueta", 17007 Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain.
  • Oliveras-Cañellas N; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdIBGi) and Hospital of Girona "Dr Josep Trueta", 17007 Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain.
  • Ricart W; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdIBGi) and Hospital of Girona "Dr Josep Trueta", 17007 Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain.
  • Karmali PP; Arcturus Therapeutics, San Diego, CA 92121, USA.
  • Tachikawa K; Arcturus Therapeutics, San Diego, CA 92121, USA.
  • Chivukula P; Arcturus Therapeutics, San Diego, CA 92121, USA.
  • Villarroya F; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain; Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine (IBUB), University of Barcelona, Av. Diagonal 643, 08028 Barcelona, Catalonia, Spain.
  • Giralt M; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain; Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine (IBUB), University of Barcelona, Av. Diagonal 643, 08028 Barcelona, Catalonia, Spain.
  • López M; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain; NeurObesity Group, Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela 15782, Spain.
  • Fernández-Real JM; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdIBGi) and Hospital of Girona "Dr Josep Trueta", 17007 Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain.
  • Moreno-Navarrete JM; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdIBGi) and Hospital of Girona "Dr Josep Trueta", 17007 Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Spain. Electronic address: jmoreno@idibg
Biomed Pharmacother ; 151: 113156, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35643066
ABSTRACT
BACKGROUND AND

AIMS:

The sexual dimorphism in fat-mass distribution and circulating leptin and insulin levels is well known, influencing the progression of obesity-associated metabolic disease. Here, we aimed to investigate the possible role of lipopolysaccharide-binding protein (LBP) in this sexual dimorphism.

METHODS:

The relationship between plasma LBP and fat mass was evaluated in 145 subjects. The effects of Lbp downregulation, using lipid encapsulated unlocked nucleomonomer agent containing chemically modified-siRNA delivery system, were evaluated in mice.

RESULTS:

Plasma LBP levels were associated with fat mass and leptin levels in women with obesity, but not in men with obesity. In mice, plasma LBP downregulation led to reduced weight, fat mass and leptin gain after a high-fat and high-sucrose diet (HFHS) in females, in parallel to increased expression of adipogenic and thermogenic genes in visceral adipose tissue. This was not observed in males. Plasma LBP downregulation avoided the increase in serum LPS levels in HFHS-fed male and female mice. Serum LPS levels were positively correlated with body weight and fat mass gain, and negatively with markers of adipose tissue function only in female mice. The sexually dimorphic effects were replicated in mice with established obesity. Of note, LBP downregulation led to recovery of estrogen receptor alpha (Esr1) mRNA levels in females but not in males.

CONCLUSION:

LBP seems to exert a negative feedback on ERα-mediated estrogen action, impacting on genes involved in thermogenesis. The known decreased estrogen action and negative effects of metabolic endotoxemia may be targeted through LBP downregulation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lipopolissacarídeos / Leptina Limite: Animals / Female / Humans / Male Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lipopolissacarídeos / Leptina Limite: Animals / Female / Humans / Male Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha